560 related articles for article (PubMed ID: 6531278)
1. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
2. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
Turjanmaa K; Salo H; Reunala T
Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
[TBL] [Abstract][Full Text] [Related]
3. PUVA treatment and skin cancer: A follow-up study.
Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
[TBL] [Abstract][Full Text] [Related]
4. Skin carcinomas and treatment with photochemotherapy (PUVA).
Lindskov R
Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
[TBL] [Abstract][Full Text] [Related]
5. Trioxsalen bath plus UVA treatment of psoriasis. Plasma concentration of the drug and clinical results.
Salo OP; Lassus A; Taskinen J
Acta Derm Venereol; 1981; 61(6):551-4. PubMed ID: 6177169
[TBL] [Abstract][Full Text] [Related]
6. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions.
Ros AM; Wennersten G; Lagerholm B
Acta Derm Venereol; 1983; 63(3):215-21. PubMed ID: 6192634
[TBL] [Abstract][Full Text] [Related]
7. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
Väätäinen N; Hollmen A; Fräki JE
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):52-5. PubMed ID: 3980803
[TBL] [Abstract][Full Text] [Related]
8. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA.
Eskelinen A; Halme K; Lassus A; Idänpään-Heikkilä J
Photodermatol; 1985 Feb; 2(1):10-4. PubMed ID: 3982991
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
[TBL] [Abstract][Full Text] [Related]
10. Long term results of topical trioxsalen PUVA in lichen planus and nodular prurigo.
Karvonen J; Hannuksela M
Acta Derm Venereol Suppl (Stockh); 1985; 120():53-5. PubMed ID: 3869416
[TBL] [Abstract][Full Text] [Related]
11. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
Henseler T; Christophers E
Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
[TBL] [Abstract][Full Text] [Related]
12. Shower PUVA: a novel variant of photochemotherapy. Distribution of photosensitivity and accumulation of trioxsalen in the skin.
Sánchez Ruderisch H; Aryee-Boi J; Schwarz C; Radenhausen M; Tebbe B
Skin Pharmacol Physiol; 2004; 17(3):129-32. PubMed ID: 15087592
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
Trott J; Gerber W; Hammes S; Ockenfels HM
Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
[TBL] [Abstract][Full Text] [Related]
15. PUVA-treated psoriatic skin as a model for cutaneous wrinkling assessed by skin replicas.
Brazzelli V; Borroni G; Berardesca E; Romano E; Vignoli GP; Rabbiosi G
Acta Derm Venereol Suppl (Stockh); 1994; 186():162-3. PubMed ID: 8073823
[TBL] [Abstract][Full Text] [Related]
16. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
Koulu L; Jansén CT
Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
[TBL] [Abstract][Full Text] [Related]
17. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
[TBL] [Abstract][Full Text] [Related]
18. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
20. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]